{"id":"https://openalex.org/W3084806402","doi":"https://doi.org/10.26442/00403660.2020.07.000818","title":"Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy","display_name":"Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy","publication_year":2020,"publication_date":"2020-09-01","ids":{"openalex":"https://openalex.org/W3084806402","doi":"https://doi.org/10.26442/00403660.2020.07.000818","mag":"3084806402","pmid":"https://pubmed.ncbi.nlm.nih.gov/33346448"},"language":"ru","primary_location":{"id":"doi:10.26442/00403660.2020.07.000818","doi":"https://doi.org/10.26442/00403660.2020.07.000818","is_oa":true,"landing_page_url":"https://doi.org/10.26442/00403660.2020.07.000818","pdf_url":"https://ter-arkhiv.ru/0040-3660/article/download/43127/pdf","source":{"id":"https://openalex.org/S27897580","display_name":"Terapevticheskii arkhiv","issn_l":"0040-3660","issn":["0040-3660","2309-5342"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","jufo-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4320800547","host_organization_name":"Consilium Medicum","host_organization_lineage":["https://openalex.org/P4320800547"],"host_organization_lineage_names":["Consilium Medicum"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://ter-arkhiv.ru/0040-3660/article/download/43127/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071809163","display_name":"Vadim V. Ptushkin","orcid":"https://orcid.org/0000-0002-9368-6050","observed_orcids":["https://orcid.org/0000-0002-9368-6050"]},"institutions":[{"id":"https://openalex.org/I4210121251","display_name":"Botkin Hospital","ror":"https://ror.org/01xbp4f63","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210121251"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"V. V. Ptushkin","raw_affiliation_strings":["Botkin City Clinical Hospital"],"raw_orcid":"https://orcid.org/0000-0002-9368-6050","affiliations":[{"raw_affiliation_string":"Botkin City Clinical Hospital","institution_ids":["https://openalex.org/I4210121251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027516224","display_name":"Alexander Kulagin","orcid":"https://orcid.org/0000-0002-9589-4136","observed_orcids":["https://orcid.org/0000-0002-9589-4136"]},"institutions":[{"id":"https://openalex.org/I2799540354","display_name":"First Pavlov State Medical University of St. Petersburg","ror":"https://ror.org/04g525b43","country_code":"RU","type":"education","lineage":["https://openalex.org/I2799540354"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. D. Kulagin","raw_affiliation_strings":["Pavlov First Saint Petersburg State Medical University"],"raw_orcid":"https://orcid.org/0000-0002-9589-4136","affiliations":[{"raw_affiliation_string":"Pavlov First Saint Petersburg State Medical University","institution_ids":["https://openalex.org/I2799540354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045319976","display_name":"Elena Lukina","orcid":"https://orcid.org/0000-0002-8774-850X","observed_orcids":["https://orcid.org/0000-0002-8774-850X"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E. A. Lukina","raw_affiliation_strings":["National Hematology Medical Research Center"],"raw_orcid":"https://orcid.org/0000-0002-8774-850X","affiliations":[{"raw_affiliation_string":"National Hematology Medical Research Center","institution_ids":["https://openalex.org/I4210100648"]}]},{"author_position":"middle","author":{"id":null,"display_name":"I. L. Davydkin","orcid":"https://orcid.org/0000-0003-0645-7645","observed_orcids":["https://orcid.org/0000-0003-0645-7645"]},"institutions":[{"id":"https://openalex.org/I4210127240","display_name":"Samara State Medical University","ror":"https://ror.org/02z5czc07","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210127240"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"I. L. Davydkin","raw_affiliation_strings":["Samara State Medical University"],"raw_orcid":"https://orcid.org/0000-0003-0645-7645","affiliations":[{"raw_affiliation_string":"Samara State Medical University","institution_ids":["https://openalex.org/I4210127240"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103118399","display_name":"Tatiana S. Konstantinova","orcid":"https://orcid.org/0000-0003-4687-0784","observed_orcids":["https://orcid.org/0000-0003-4687-0784"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. S. Konstantinova","raw_affiliation_strings":["Sverdlovsk Regional Clinical Hospital \u21161"],"raw_orcid":"https://orcid.org/0000-0003-4687-0784","affiliations":[{"raw_affiliation_string":"Sverdlovsk Regional Clinical Hospital \u21161","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005606446","display_name":"\u0412. \u0421. \u0428\u0430\u043c\u0440\u0430\u0439","orcid":"https://orcid.org/0000-0002-3254-4788","observed_orcids":["https://orcid.org/0000-0002-3254-4788"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. S. Shamrai","raw_affiliation_strings":["Rostov Regional Clinical Hospital"],"raw_orcid":"https://orcid.org/0000-0002-3254-4788","affiliations":[{"raw_affiliation_string":"Rostov Regional Clinical Hospital","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005032616","display_name":"Natalia V. Minaeva","orcid":"https://orcid.org/0000-0002-8479-3217","observed_orcids":["https://orcid.org/0000-0002-8479-3217"]},"institutions":[{"id":"https://openalex.org/I4210110158","display_name":"Kirov Research Institute of Hematology and Blood Transfusion FMBA","ror":"https://ror.org/01yetjs28","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210110158","https://openalex.org/I64264942"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"N. V. Minaeva","raw_affiliation_strings":["Kirov Research Institute of Hematology and Blood Transfusion"],"raw_orcid":"https://orcid.org/0000-0002-8479-3217","affiliations":[{"raw_affiliation_string":"Kirov Research Institute of Hematology and Blood Transfusion","institution_ids":["https://openalex.org/I4210110158"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001572944","display_name":"Dmitry Anatolievich Kudlay","orcid":"https://orcid.org/0000-0003-1878-4467","observed_orcids":["https://orcid.org/0000-0003-1878-4467"]},"institutions":[{"id":"https://openalex.org/I4405272539","display_name":"Generium Pharmaceuticals (Russia)","ror":"https://ror.org/04anvdv29","country_code":"RU","type":"company","lineage":["https://openalex.org/I4405272539"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"D. A. Kudlay","raw_affiliation_strings":["JSC GENERIUM"],"raw_orcid":"https://orcid.org/0000-0003-1878-4467","affiliations":[{"raw_affiliation_string":"JSC GENERIUM","institution_ids":["https://openalex.org/I4405272539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036222383","display_name":"Elena V. Gapchenko","orcid":"https://orcid.org/0000-0002-6817-5531","observed_orcids":["https://orcid.org/0000-0002-6817-5531"]},"institutions":[{"id":"https://openalex.org/I4405272539","display_name":"Generium Pharmaceuticals (Russia)","ror":"https://ror.org/04anvdv29","country_code":"RU","type":"company","lineage":["https://openalex.org/I4405272539"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E. V. Gapchenko","raw_affiliation_strings":["JSC GENERIUM"],"raw_orcid":"https://orcid.org/0000-0002-6817-5531","affiliations":[{"raw_affiliation_string":"JSC GENERIUM","institution_ids":["https://openalex.org/I4405272539"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035417997","display_name":"\u041e. \u0410. Markova","orcid":"https://orcid.org/0000-0002-1179-3881","observed_orcids":["https://orcid.org/0000-0002-1179-3881"]},"institutions":[{"id":"https://openalex.org/I4405272539","display_name":"Generium Pharmaceuticals (Russia)","ror":"https://ror.org/04anvdv29","country_code":"RU","type":"company","lineage":["https://openalex.org/I4405272539"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"O. A. Markova","raw_affiliation_strings":["JSC GENERIUM"],"raw_orcid":"https://orcid.org/0000-0002-1179-3881","affiliations":[{"raw_affiliation_string":"JSC GENERIUM","institution_ids":["https://openalex.org/I4405272539"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069705379","display_name":"A.Yu. Borozinets","orcid":"https://orcid.org/0000-0002-4863-8471","observed_orcids":["https://orcid.org/0000-0002-4863-8471"]},"institutions":[{"id":"https://openalex.org/I4405272539","display_name":"Generium Pharmaceuticals (Russia)","ror":"https://ror.org/04anvdv29","country_code":"RU","type":"company","lineage":["https://openalex.org/I4405272539"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. Yu. Borozinets","raw_affiliation_strings":["JSC GENERIUM"],"raw_orcid":"https://orcid.org/0000-0002-4863-8471","affiliations":[{"raw_affiliation_string":"JSC GENERIUM","institution_ids":["https://openalex.org/I4405272539"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9684,"has_fulltext":true,"cited_by_count":36,"citation_normalized_percentile":{"value":0.87835673,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"92","issue":"7","first_page":"77","last_page":"84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9702000021934509,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.026100000366568565,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paroxysmal-nocturnal-hemoglobinuria","display_name":"paroxysmal nocturnal hemoglobinuria","score":0.9319999814033508},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7329999804496765},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9990000128746033},{"id":"https://openalex.org/keywords/complement-c5a-receptor-inhibition","display_name":"complement C5a receptor inhibition","score":0.652999997138977},{"id":"https://openalex.org/keywords/membrane-attack-complex","display_name":"membrane attack complex","score":0.890999972820282},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.8679999709129333},{"id":"https://openalex.org/keywords/immunogenicity","display_name":"immunogenicity","score":0.7170000076293945},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.6320000290870667},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.7319999933242798},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5540000200271606},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.5230000019073486},{"id":"https://openalex.org/keywords/intravascular-hemolysis","display_name":"intravascular hemolysis","score":0.8500000238418579}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9461207389831543},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.8856271505355835},{"id":"https://openalex.org/C2777991916","wikidata":"https://www.wikidata.org/wiki/Q421617","display_name":"Eculizumab","level":4,"score":0.857529878616333},{"id":"https://openalex.org/C2777346216","wikidata":"https://www.wikidata.org/wiki/Q1479494","display_name":"Paroxysmal nocturnal hemoglobinuria","level":2,"score":0.840198814868927},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6827119588851929},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6036612391471863},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5370776653289795},{"id":"https://openalex.org/C3019800554","wikidata":"https://www.wikidata.org/wiki/Q3813242","display_name":"Open label","level":3,"score":0.503114640712738},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4772208333015442},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3284812569618225},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.30351078510284424},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13587942719459534},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.081383615732193},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006457","descriptor_name":"Hemoglobinuria, Paroxysmal","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012426","descriptor_name":"Russia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.26442/00403660.2020.07.000818","doi":"https://doi.org/10.26442/00403660.2020.07.000818","is_oa":true,"landing_page_url":"https://doi.org/10.26442/00403660.2020.07.000818","pdf_url":"https://ter-arkhiv.ru/0040-3660/article/download/43127/pdf","source":{"id":"https://openalex.org/S27897580","display_name":"Terapevticheskii arkhiv","issn_l":"0040-3660","issn":["0040-3660","2309-5342"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","jufo-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4320800547","host_organization_name":"Consilium Medicum","host_organization_lineage":["https://openalex.org/P4320800547"],"host_organization_lineage_names":["Consilium Medicum"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"journal-article"},{"id":"pmid:33346448","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33346448","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:doaj.org/article:c8727c8295774e18b3a446395b05b823","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c8727c8295774e18b3a446395b05b823","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432, Vol 92, Iss 7, Pp 77-84 (2020)","raw_type":"article"},{"id":"mag:3108665462","doi":null,"is_oa":true,"landing_page_url":"https://ter-arkhiv.ru/0040-3660/article/download/43127/pdf","pdf_url":null,"source":{"id":"https://openalex.org/S27897580","display_name":"Terapevticheskii arkhiv","issn_l":"0040-3660","issn":["0040-3660","2309-5342"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","jufo-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4320800547","host_organization_name":"Consilium Medicum","host_organization_lineage":["https://openalex.org/P4320800547"],"host_organization_lineage_names":["Consilium Medicum"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":null,"is_accepted":false,"is_published":false,"raw_source_name":"\u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432","raw_type":null}],"best_oa_location":{"id":"doi:10.26442/00403660.2020.07.000818","doi":"https://doi.org/10.26442/00403660.2020.07.000818","is_oa":true,"landing_page_url":"https://doi.org/10.26442/00403660.2020.07.000818","pdf_url":"https://ter-arkhiv.ru/0040-3660/article/download/43127/pdf","source":{"id":"https://openalex.org/S27897580","display_name":"Terapevticheskii arkhiv","issn_l":"0040-3660","issn":["0040-3660","2309-5342"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","jufo-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4320800547","host_organization_name":"Consilium Medicum","host_organization_lineage":["https://openalex.org/P4320800547"],"host_organization_lineage_names":["Consilium Medicum"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3084806402.pdf","grobid_xml":"https://content.openalex.org/works/W3084806402.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1201749067","https://openalex.org/W1582047783","https://openalex.org/W1978700432","https://openalex.org/W1981652493","https://openalex.org/W2023377972","https://openalex.org/W2038485892","https://openalex.org/W2171068466","https://openalex.org/W2286611464","https://openalex.org/W2559144607","https://openalex.org/W2563259527","https://openalex.org/W2736726321","https://openalex.org/W2802751991","https://openalex.org/W2889134887","https://openalex.org/W2907958219","https://openalex.org/W2914026007","https://openalex.org/W2989356400","https://openalex.org/W3009755139"],"related_works":["https://openalex.org/W4417013178","https://openalex.org/W3196114252","https://openalex.org/W2989356400","https://openalex.org/W4404672281","https://openalex.org/W4210510843","https://openalex.org/W4313450480","https://openalex.org/W4401739854","https://openalex.org/W4310106540","https://openalex.org/W2124180683","https://openalex.org/W4389220280"],"abstract_inverted_index":{"Currently,":[0],"the":[1,6,14,22,26,31,47,63,66,71,83,87,94,107,111,145,151,170,177,180,186,188,200,203,214,217,226,243,252,255,260,264,278,287,310,314,317,334,337,341,351,360,369,377,380,398,411,417,421,438,444],"main":[2],"pathogenetic":[3],"method":[4],"for":[5,46,76,165],"treatment":[7,15,48,396],"of":[8,25,49,65,70,86,106,114,144,158,179,202,209,216,242,254,263,280,290,309,316,319,326,336,362,379,416,423,443],"paroxysmal":[9],"nocturnal":[10],"hemoglobinuria":[11],"(PNH)":[12],"is":[13,30,36,54],"with":[16,40,51,120,130,150,237,321,350,376,397,430],"recombinant":[17],"monoclonal":[18,38],"antibodies":[19,389],"that":[20,176],"block":[21],"C5":[23],"component":[24],"complement":[27],"system.":[28],"Eculizumab":[29],"first":[32,84,261],"biotechnological":[33],"drug,":[34,353,400],"which":[35,53,401],"a":[37,156,163,197,249,283,302,324,330,348,372],"antibody,":[39],"proven":[41],"clinical":[42,58,171],"efficacy":[43,241],"and":[44,73,96,103,192,282,307,332,413,440],"safety":[45,102,439],"patients":[50,119,129,236,429],"PNH,":[52,431],"used":[55],"in":[56,62,110,116,235,251,277,286,305,359,420,426],"world":[57],"practice.":[59],"In":[60,383],"Russia,":[61],"framework":[64],"state":[67],"program":[68],"Development":[69],"pharmaceutical":[72],"medical":[74],"industry":[75],"20132020":[77],"was":[78,148,174,190,246,266],"developed":[79],"Elizaria":[80,154,245,322,419],"(JSC":[81],"GENERIUM)":[82],"biosimilar":[85],"original":[88],"drug":[89,108,153,182,219,244,265,418],"eculizumab.":[90,142],"AIM:":[91],"To":[92],"evaluate":[93],"pharmacokinetic":[95,412],"pharmacodynamic":[97,240,414],"parameters,":[98],"as":[99,101],"well":[100],"immunogenicity":[104,442],"parameters":[105],"Elizara":[109],"induction":[112,318,424],"phase":[113],"therapy":[115,320,425],"previously":[117,140,427],"untreated":[118,428],"PNH.":[121,238],"MATERIALS":[122],"AND":[123],"METHODS:":[124],"The":[125,206,239,408,435],"study":[126,146,218,338,409,436,445],"included":[127],"11":[128],"PNH":[131],"aged":[132],"26":[133],"to":[134,196,230,293,298,368],"75":[135],"years":[136],"who":[137],"had":[138,347,371],"not":[139],"received":[141],"Each":[143],"participants":[147],"injected":[149],"studied":[152,181,352,381,399],"at":[155,199,220,268,323],"dose":[157,325],"600":[159,327],"mg":[160,328],"intravenously":[161],"once":[162,329],"week":[164,331],"4":[166],"weeks.":[167],"RESULTS:":[168],"During":[169],"study,":[172],"it":[173],"noted":[175],"concentration":[178,208,228,253],"significantly":[183],"increased":[184],"by":[185,248],"time":[187],"infusion":[189,262,378],"completed":[191],"then":[193],"gradually":[194],"decreased":[195],"minimum":[198,227],"end":[201],"dosing":[204],"interval.":[205],"average":[207,288],"eculizumab":[210],"5":[211,295,346],"minutes":[212],"before":[213],"administration":[215],"all":[221],"visits":[222],"exceeded":[223],"35":[224],"g/ml,":[225],"sufficient":[229],"completely":[231],"inhibit":[232],"intravascular":[233],"hemolysis":[234],"confirmed":[247,333],"decrease":[250,276,285,304],"membrane-attack":[256],"complex":[257],"(MAC)":[258],"after":[259],"maintained":[267],"stable":[269],"levels":[270],"until":[271],"visit":[272,294],"5.":[273],"A":[274],"persistent":[275],"level":[279],"MAC":[281],"four-fold":[284],"values":[289],"lactate":[291],"dehydrogenase":[292],"from":[296],"1286.4":[297],"280.9":[299],"U/l":[300],"demonstrated":[301,437],"marked":[303],"activity":[306,394],"stabilization":[308],"hemolytic":[311],"process":[312],"against":[313],"background":[315],"effecacy":[335],"drug.":[339,382,446],"Among":[340],"9":[342],"adverse":[343,357],"events,":[344],"only":[345],"relationship":[349,375],"including":[354],"one":[355],"serious":[356],"event":[358],"form":[361],"an":[363],"allergic":[364],"reaction,":[365],"which,":[366],"according":[367],"researcher,":[370],"possible":[373],"cause-effect":[374],"2":[384],"patients,":[385],"low-titer":[386],"binding":[387],"anti-drug":[388],"were":[390],"detected":[391],"without":[392],"neutralizing":[393],"during":[395],"may":[402],"indicate":[403],"its":[404,433],"low":[405,441],"immunogenicity.":[406],"CONCLUSION:":[407],"evaluated":[410],"properties":[415],"regimen":[422],"confirming":[432],"efficacy.":[434]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":9},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2020-09-21T00:00:00"}